丽珠集团：公司2025年共有194个产品纳入国家医保目录

Core Insights - The company, Lizhu Group, announced that a total of 194 products will be included in the National Medical Insurance Directory by 2025, comprising 92 Class A and 102 Class B products [1] Group 1 - The injectable Aripiprazole microspheres have been included in the National Medical Insurance Directory for the first time through negotiations [1] - The injectable Triptorelin acetate microspheres have a newly added indication [1] - The injectable Esomeprazole sodium has successfully renewed its contract [1]